Compatibility of a protein topical gel with wound dressings

Journal of Pharmaceutical Sciences

Volumn 98, Issue 2, 2009, Pages 595-605

  Ji, Junyan A ^a   Borisov, Oleg ^a   Ingham, Erika ^a   Ling, Victor ^a   Wang, Y John ^a  

^a GENENTECH INC   (United States)

Author keywords

Compatibility; Dressing; Leachables; Protein oxidation; rhVEGF; Topical gel formulation

Indexed keywords

METHYLCELLULOSE; RECOMBINANT VASCULOTROPIN; BISPHENOL A BIS(2 HYDROXYPROPYL) ETHER DIMETHACRYLATE; DRUG CARRIER; OPSITE; POLYURETHAN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; GEL; GEL PERMEATION CHROMATOGRAPHY; LEACHING; MASS SPECTROMETRY; OXIDATION; PROTEIN STABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; WOUND CARE; WOUND DRESSING; ADHESION; BANDAGE; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; DRUG STABILITY; ENDOTHELIUM CELL; EQUIPMENT DESIGN; GEL CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRADERMAL DRUG ADMINISTRATION; OXIDATION REDUCTION REACTION; PROTEIN DENATURATION; TIME; WOUND HEALING;

ADHESIVENESS; ADMINISTRATION, CUTANEOUS; BANDAGES; BISPHENOL A-GLYCIDYL METHACRYLATE; CELL PROLIFERATION; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; ENDOTHELIAL CELLS; EQUIPMENT DESIGN; GELS; HUMANS; MASS SPECTROMETRY; METHYLCELLULOSE; OXIDATION-REDUCTION; POLYURETHANES; PROTEIN DENATURATION; PROTEIN STABILITY; RECOMBINANT PROTEINS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 59849083566     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21465     Document Type: Article

References (19)

1. Queen D, Orsted H, Sanada H, Sussman G. 2004. A dressing history. Int Wound J 1:59-77.
2. Doughty D. 2005. Dressings and more: Guidelines for topical woundmanagement. Nurs Clin North Am 40:217-231.
3. Paddle-Ledinek JE, Nasa Z, Cleland HJ. 2006. Effect of different wound dressings on cell viability and proliferation. Plas Reconstr Surg 117:110S-118S.
4. Turner TD, Spyratou O, Schmidt R. 1989. Biocompatibility of wound management products: Standardization of and determination of cell growth rate in L929 fibroblast cultures. J Pharm Pharmacol 41:775-780.
5. Greenhalgh DG. 1996. The role of growth factors in wound healing. J Trauma Inj Infect Crit Care 41:159-167.
6. Mann A, Niekisch K, Schirmacher P, Blessing M. 2006. Granulocyte- macrophage colony-stimulating factor is essential for normal wound healing. J Investig Dermatol Symp Proc 11:87-92.
7. Boateng JS, Matthews KH, Stevens HNE, Eccleston GM. 2007. Wound healing dressings and drug delivery systems: A review. J Pharm Sci 97:2892-2923.
8. Finetti G, Farina M. 1992. Recombinant human basic-fibroblastic growth factor: Different medical dressings for clinical application in wound healing. Il Farmaco 47:967-978.
9. Breen TJ, Bunting S, Samba CP. 2006. Wound healing. WO 2006/138468.
10. Vries CD, Escobedo JA, Ueno H, Houck KA, Ferrara N, Williams LT. 1992. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
11. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. 1994. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988-26995.
12. Duenas E, Keck R, DeVos A, Jones AJ, Cleland JL. 2001. Comparison between light induced and chemically induced oxidation of rhVEGF. Pharm Res 18:1455-1460.
13. Worthington Enzyme Manual, 1993 Edition.
14. Dienes D, Börjesson J, Hägglund P, Tjerneld F, Lidén G, Réczey K, Stålbrand H. 2007. Identification of a trypsin-like serine protease from Trichoderma reesei QM9414. Enzyme Microb Technol 40:1087-1094.
15. Houde D, Kauppinen P, Mhatre R, Lyubarskaya Y. 2006. Determination of protein oxidation by mass spectrometry and method transfer to quality control. J Chromatogr A 1123:189-198.
16. Silva JC, Gorenstein MV, Li G-Z, Vissers JPC, Geromanos S. 2006. Absolute quantification of proteins by LCMS. J Mol Cellular Proteom 5:144-156.
17. Wasylaschuk WR, Harmon PA, Wagner G, Harman AB, Templeton AC, Xu H, Reed RA. 2007.Evaluation of hydroperoxides in common pharmaceutical excipients. J Pharm Sci 96:106-116.
18. Ha E, Wang W, Wang YJ. 2002. Peroxide formation in polysorbate 80 and protein stability. J Pharm Sci 91:2252-2264.
19. Thomas S, Loveless P. 1988. Comparative review of the properties six semipermeable film dressing. Pharm J 240:785-787.